SMCX

Defiance Daily Target 2X Long SMCI ETF
SMCX

31.56 USD
-12.92
29.05%
Updated Jan 27, 2:52 PM EST
1 day
-29.05%
5 days
-20.72%
1 month
-27.23%
3 months
-99.19%
6 months
-99.58%
Year to date
-17.40%
1 year
-99.58%
5 years
-99.58%
10 years
-99.58%
0
Funds holding %
of 6,831 funds
–
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

25.78% more ownership

Funds ownership: 0% [Q2] → 25.78% (+25.78%) [Q3]

35% less call options, than puts

Call options by funds: $101K | Put options by funds: $156K

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for SMCX.

See Analyst Rankings

Financial journalist opinion

Neutral
See It Market
1 week ago
ETF Splits Surge: What Does It Mean For Investors?
Something unusual came down the chimney late last year. During the holidays and the preceding weeks, there were a slew of splits among US ETFs – the most in the past four years, according to Wall Street Horizon's data.
ETF Splits Surge: What Does It Mean For Investors?
Negative
Seeking Alpha
3 weeks ago
SMCX: Showcasing The Dangers Of Leveraged ETFs
Super Micro Computer, Inc. faces regulatory issues and a significant stock decline, making it unsuitable for leveraged plays like the SMCX ETF. Leveraged ETFs like SMCX amplify losses due to daily resets and swap agreements, making them risky during SMCI's current negative momentum. Despite regulatory hurdles, SMCI's strong customer base, including Nvidia, and solid revenue projections support a long-term bullish outlook on the stock.
SMCX: Showcasing The Dangers Of Leveraged ETFs
Neutral
ETF Trends
1 month ago
New Defiance Single-Stock ETF Tracks NOVO Nordisk Performance
Defiance ETFs added another single-stock ETF to its lineup, bringing the total number of 2x leveraged single-stock funds in its offering to five.
New Defiance Single-Stock ETF Tracks NOVO Nordisk Performance
See News Rankings
Charts implemented using Lightweight Charts™